These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20457501)

  • 21. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
    Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
    Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Gasex on pharmacokinetic profile of ciprofloxacin in healthy male volunteers.
    Mitra SK; Sundaram R
    Indian J Exp Biol; 1997 Jul; 35(7):799-800. PubMed ID: 9418382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of food on fluoride bioavailability].
    Trautner K
    Z Stomatol; 1989 Nov; 86(7):393-9. PubMed ID: 2638084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro monitoring of ciprofloxacin antacids interactions by UV & HPLC.
    Sultana N; Arayne MS; Hussain F
    Pak J Pharm Sci; 2005 Oct; 18(4):23-31. PubMed ID: 16380354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity.
    Ogata H; Aoyagi N; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):279-82. PubMed ID: 3733276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2009 Dec; (4):141-6. PubMed ID: 20183991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
    Weidekamm E; Stöckel K; Dell D
    Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
    Aramayona JJ; Mora J; Fraile LJ; García MA; Abadía AR; Bregante MA
    Am J Vet Res; 1996 Apr; 57(4):547-53. PubMed ID: 8712523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.
    Klueglich M; Ring A; Scheuerer S; Trommeshauser D; Schuijt C; Liepold B; Berndl G
    J Clin Pharmacol; 2005 Sep; 45(9):1055-61. PubMed ID: 16100300
    [No Abstract]   [Full Text] [Related]  

  • 38. Biopharmaceutical characterization of ciprofloxacin HCl-ferrous sulfate interaction.
    Parojčić J; Stojković A; Tajber L; Grbić S; Paluch KJ; Djurić Z; Corrigan OI
    J Pharm Sci; 2011 Dec; 100(12):5174-84. PubMed ID: 21789771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe.
    Beckebaum S; Bircher J; Gallenkamp H
    Eur J Clin Pharmacol; 1996; 50(6):511-2. PubMed ID: 8858281
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of food components on the intrinsic dissolution rate of ketoconazole.
    Ghazal HS; Dyas AM; Ford JL; Hutcheon GA
    Drug Dev Ind Pharm; 2015; 41(10):1647-54. PubMed ID: 26288994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.